| 
			  
			
 
  by Lyndsay Moss
 
			
			Spanish version05 August 2008
 
			from
			
			ScotsmanNews Website 
			  
			INJECTIONS of vitamin 
			C could halve the growth of cancerous tumors, research suggested 
			yesterday.
 A study in the United States found that the vitamin could prove 
			useful in treating cancers for which few other options currently 
			exist. The breakthrough, which comes following tests on mice, 
			follows decades of research into the potential of 
			vitaADVERTISEMENTmin C in tackling cancer. However, experts warned 
			that the benefits of the vitamin had yet to be demonstrated in human 
			patients.
 
 For the latest study, researchers from the National Institutes of 
			Health in Bethesda, Maryland, examined the effects of vitamin C on 
			cells grown in laboratories. Two hours of exposure to the vitamin 
			significantly cut the survival of ovarian, pancreatic and brain 
			tumor (glioblastoma) cancer cells.
 
 Similar results were seen when cancer-ridden mice were injected with 
			vitamin C. The therapy halved the growth of aggressive tumors, 
			killing cancer cells while leaving healthy tissue unharmed.
 
 It is thought the discovery could provide a new lifeline for 
			patients with a poor prognosis and few other options. Tackling 
			cancer with vitamin C would also have the added advantage of being 
			cheap compared with many of the very expensive cancer treatments.
 
 Usually the body keeps a tight rein on high vitamin C levels in the 
			blood. But the scientists found that the mechanism can be by-passed 
			if the vitamin is injected straight into the blood instead of 
			passing through the digestive system. When this is done it releases 
			the powerful anti-cancer potential of the vitamin, according to the 
			researchers writing in the journal Proceedings of the National 
			Academy of Sciences.
 
 The experiments showed that high levels of vitamin C in the blood 
			generate hydrogen peroxide, which is lethal to tumors. The 
			chemical forms in the spaces between cancer cells, damaging 
			membranes, upsetting metabolism and scrambling the DNA of the tumor.
 
 Even the growth of aggressive cancers was held back in the 
			experiments. But healthy tissues appeared to resist the effects.
 
 The use of high-dose vitamin C as an alternative cancer treatment 
			has a long history dating back to the 1970s. Patients have taken the 
			vitamin both by mouth and intravenously, but with mixed results in 
			scientific trials. For this reason, claims that vitamin C can treat 
			cancer have been dismissed by conventional cancer experts. But the 
			new investigation, led by Dr Qi Chen, may help to start 
			changing attitudes towards this approach.
 
 The scientists said:
 
				
				"Pharmacologic 
				concentrations of ascorbate (the chemical name for 
				vitamin C] decreased tumor volumes 41-53 per cent in diverse 
				cancer types known for both their aggressive growth and limited 
				treatment options." 
			Dr Alison Ross, science 
			information officer at Cancer Research UK, said:  
				
				"This is encouraging 
				work but it's at a very early stage because it involves cells 
				grown in the lab and mice." 
			
 
 
			
 
 
 Cancer hopes as...
 
			
			
			Vitamin C injections kill mice tumors 
			by William Tinning 
			August 05 2008 from 
			TheHerald Website
 
			  
			Vitamin C that is 
			injected rather than swallowed could provide a new lifeline for 
			cancer patients with a poor prognosis and few treatment options, 
			according to new research. Scientists say the therapy halved the 
			growth of aggressive tumors in mice, killing cancer cells while 
			leaving healthy tissue unharmed.
 Tackling cancer with vitamin C would also have the added advantage 
			of being less expensive, the research claims. The body usually keeps 
			tight control of vitamin C levels in the blood.
 
 However, a new US-based investigation, led by Dr Qi Chen from 
			the National Institutes of Health in Maryland, Ohio, found 
			that the mechanism can be by-passed if the vitamin is injected 
			straight into the bloodstream instead of passing through the 
			digestive system. When this is done it releases the powerful 
			anti-cancer potential of the vitamin.
 
 Experiments showed that high levels of vitamin C in the blood 
			generate hydrogen peroxide, which is lethal to tumors. The 
			chemical forms in the spaces between cancer cells, damaging 
			membranes, upsetting metabolism and scrambling DNA.
 
 Even the growth of aggressive, hard-to-treat cancers was held back 
			in the studies. But healthy tissues appeared to resist the effects.
 
 The use of high-dose vitamin C as a complementary or alternative 
			cancer treatment was first promoted in the 1970s. Patients have 
			taken the vitamin both by mouth and intravenously. But despite some 
			positive outcomes, there has been insufficient reliable evidence 
			that the therapy works leading conventional cancer experts to 
			dismiss claims that vitamin C can treat cancer.
 
 Dr Chen's investigation involved testing the effects of vitamin C on 
			laboratory cell lines and cancer-ridden mice. Laboratory tests 
			showed that two hours of exposure to the vitamin significantly 
			reduced the survival of ovarian, pancreatic and brain tumor cancer 
			cells. Similar results were achieved when mice bearing the same 
			kinds of tumors were injected with vitamin C.
 
 Writing in the journal Proceedings of the National Academy of 
			Sciences, the scientists said:
 
				
				"Pharmacologic 
				concentrations of ascorbate decreased tumor volumes 
				41-53% in diverse cancer types known for both their aggressive 
				growth and limited treatment options." 
			They said a "rapid and 
			sustained increase" in hydrogen peroxide was detected in tumor 
			fluids within 30 minutes of the treatment commencing.
 An early stage patient study showed that similar therapeutic levels 
			of vitamin C in the blood could be achieved when ascorbate 
			was administered intravenously in humans.
 
 The scientist added:
 
				
				"A regimen of daily 
				pharmacologic ascorbate treatment significantly decreased 
				growth rates of ovarian, pancreatic and glioblastoma 
				tumors established in mice.
 "Similar pharmacologic concentrations were readily achieved in 
				humans given ascorbate intravenously. These data suggest 
				that ascorbate as a prodrug may have benefits in 
				cancers with poor prognosis and limited therapeutic options."
 
			Dr Alison Ross, 
			science information officer at Cancer Research UK, said:
			 
				
				"This is encouraging 
				work but it's at a very early stage because it involves cells 
				grown in the lab and mice. Much more research is needed before 
				we'll know whether vitamin C could be a viable cancer treatment 
				in the future.
 "There is currently no evidence from clinical trials in humans 
				that injecting or consuming vitamin C is an effective way to 
				treat cancer. Some research even suggests that high doses of 
				antioxidants can make cancer treatment less effective, reducing 
				the benefits of radiotherapy and chemotherapy."
 
			Vitamin C supplements 
			have been hailed since the 1970s as an aid for fighting colds, 
			principally thanks to the US Nobel Prizewinning chemist Dr Linus 
			Pauling, who championed it.
 However, in July last year, Australian and Finnish scientists 
			describe d the claim as a myth, saying that there was no evidence 
			that, for the average person, taking extra vitamin C can stop 
			coughs and sneezes.
 
 
			   |